Moreover, in a recent kinome-wide CRISPR/Cas9 knockout screening, which has identified several kinases whose deficiency improves chemotherapy efficacy in MM, WEE1 knockout has proved to induce the most significant effect [66]. The gene discussed is WEE1; the disease is Miyoshi myopathy.